Clinicopathologic and Genomic Factors Impacting Efficacy of First-Line Chemoimmunotherapy in Advanced NSCLCJoao V. Alessi, Mark M. Awad, Giuseppe Lamberti et al.|Journal of Thoracic Oncology|2023Cited by 91
Minimal residual disease in patients with diffuse large B-cell lymphoma undergoing autologous stem cell transplantationReid W. Merryman, Philippe Armand, Robert Redd et al.|Blood Advances|2022Cited by 19
Interim Positron Emission Tomography During Frontline Chemoimmunotherapy for Follicular LymphomaReid W. Merryman, Heather A. Jacene, Laure Michaud et al.|HemaSphere|2023Cited by 11